Association of CAA and TATC Insertion/Deletion Genetic Polymorphisms in RTN4 3'-UTR with Hepatocellular Carcinoma Risk

被引:4
|
作者
Wang, NaNa [1 ]
Chen, KeYu [2 ]
Xu, Jia [1 ]
Yuan, Fang [3 ]
Li, HongYu [4 ]
Deng, FengMei [5 ]
Zhang, LuShun [5 ]
机构
[1] Chengdu Med Coll, Sch Med Lab Sci, Chengdu 610500, Sichuan, Peoples R China
[2] Chengdu Med Coll, Sch Biomed Sci, Chengdu 610500, Sichuan, Peoples R China
[3] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Immunol, Chengdu 610041, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu 610041, Peoples R China
[5] Chengdu Med Coll, Dept Neurobiol, Dept Pathol & Pathophysiol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu 610500, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; RTN4; Nogo; Polymorphisms; MESSENGER-RNA; NOGO-B; 3'-UTR; APOPTOSIS; EXPRESSION; HCC;
D O I
10.1007/s12253-017-0204-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Evidence from recent researchers suggested that RTN4 is a multifunctional gene, including tumor suppression, apoptosis, vascular remodeling, and inhibition of axonal regeneration. The CAA and TATC insertion/deletion polymorphisms (CAA/TATC polymorphisms) of RTN4 3aEuro(3)-untranslated regions (UTRs) have been linked to cervical squamous cell carcinoma (CSCC), uterine leiomyomas (UL) and non-small cell lung cancer (NSCLC). However, the association between these two polymorphisms sites with Hepatocellular Carcinoma (HCC) risk was not carry out before. A total of 284 HCC patients and 484 control subjects were recruited for this study. The RTN4 CAA/TATC insertion/deletion genotypes were determined using polymerase chain reaction (PCR) assay. The ID/DD genotypes of CAA were significantly associated with an increased risk of HCC compared with the II genotype (ID vs. II: OR = 1.50, 95% CI: 1.10-2.04; DD vs. II: OR = 2.00, 95%CI: 1.15-3.46). Meanwhile, the frequency of D allele of CAA was significantly related with an increased risk of HCC compared with the I allele (D vs. I: OR = 1.39, 95% CI: 1.12-1.73). The ID genotypes of TATC was significantly associated with an increased risk of HCC compared with the DD genotype (ID vs. DD: OR = 1.70, 95% CI: 1.23-2.33). The present study provided evidence that RTN4 CAA/TATC polymorphisms were associated with HCC development in Chinese Han population.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 48 条
  • [31] Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma
    Lee, HS
    Yoon, JH
    Kamimura, S
    Iwata, K
    Watanabe, H
    Kim, CY
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (05) : 737 - 740
  • [32] Association of ACYP2 and MPHOSPH6 genetic polymorphisms with the risk of hepatocellular carcinoma in chronic hepatitis B virus carriers
    Zhang, Yingai
    Wang, Shunlan
    Wen, Xiaohong
    Zhang, Shufang
    Yang, Yijun
    ONCOTARGET, 2017, 8 (49) : 86011 - 86019
  • [33] An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1α 3' untranslated region confers risk for hepatocellular carcinoma
    Gao, Yuzhen
    He, Yan
    Ding, Jun
    Wu, Kang
    Hu, Bo
    Liu, Yang
    Wu, Yan
    Guo, Bingnan
    Shen, Yueping
    Landi, Debora
    Landi, Stefano
    Zhou, Yifeng
    Liu, Haiyan
    CARCINOGENESIS, 2009, 30 (12) : 2064 - 2069
  • [34] Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis
    Shi, Han
    He, Hongyan
    Ojha, Suvash Chandra
    Sun, Changfeng
    Fu, Juan
    Yan, Mao
    Deng, Cunliang
    Sheng, Yunjian
    BIOSCIENCE REPORTS, 2019, 39
  • [35] Genetic variation in the HLA-G 3′UTR 14-bp insertion/deletion and the associated cancer risk: evidence from 25 case-control studies
    Jiang, You
    Lu, Jun
    Wu, Yue-E
    Zhao, Xin
    Li, Liang
    BIOSCIENCE REPORTS, 2019, 39
  • [36] Association of Genetic Polymorphisms in HSD17B1, HSD17B2 and SHBG Genes with Hepatocellular Carcinoma Risk
    Zhang, Lu Shun
    Yuan, Fang
    Guan, Xuan
    Li, Juan
    Liu, Xin Lian
    Sun, Jing
    Liu, Bo
    Ma, Wei
    Deng, Feng Mei
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (03) : 661 - 666
  • [37] Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility:: a case-control study in a high-risk region of China
    Chen, Xiaoping
    Wang, Haijian
    Xie, Weimin
    Liang, Renxiang
    Wei, Zhongliang
    Zhi, Lianteng
    Zhang, Xiumei
    Hao, Bingtao
    Zhong, Shaofei
    Zhou, Gangqiao
    Zhang, Lingqiang
    Gao, Xue
    Zhu, Yunping
    He, Fuchu
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (03): : 219 - 227
  • [38] 4-bp insertion/deletion (rs3783553) polymorphism within the 3′UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population
    Hashemi, Mohammad
    Bahari, Gholamreza
    Sarhadi, Shamim
    Eskandari, Ebrahim
    Narouie, Behzad
    Taheri, Mohsen
    Ghavami, Saeid
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (03) : 2627 - 2635
  • [39] Lack of association between 4-base pair insertion/deletion (rs3783553) polymorphism within the 3′UTR of IL1A and breast cancer: A preliminary report
    Karami, Shima
    Sarabandi, Sahel
    Pourzand, Pouria
    Tabasi, Farhad
    Hashemi, Mohammad
    Bahari, Gholamreza
    GENE REPORTS, 2021, 23
  • [40] Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis
    Zhang, Shijie
    Wu, Hexing
    Wu, Xiangwei
    Lian, Webo
    Wang, Yanchao
    Zhang, Xiaozhao
    Peng, Xinyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 6638 - 6649